643 results on '"Orloff M"'
Search Results
2. Abstract No. 28 Chemoembolization (TACE) with High-Dose 1,3-Bis-(2-Chloroethyl)-1-Nitrosourea (BCNU) for First-Line Treatment of Limited Uveal Melanoma Hepatic Metastases
3. Abstract No. 140 Hepatic Arterial Infusion of the Class C TLR9 Agonist SD-101 in Pressure Enabled Regional Immuno-Oncology (PERIO) Phase 1 Trials for Liver Tumors
4. Grundlagen technischer Systeme und des methodischen Vorgehens
5. Comment éviter la prescription (P) des médicaments potentiellement inappropriés (MPI) aux personnes âgées (PA) ? Le Pharmacien Clinicien (Pharm Clin) au cœur de l’action !
6. Sécurisation des médicaments à haut risque : quels rôles pour le pharmacien clinicien ?
7. Grundlagen der Konstruktionstechnik
8. 844P Efficacy and safety of lifileucel, an investigational autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma previously treated with anti-LAG3 antibody
9. 832P Treatment sequence with tebentafusp (tebe) and anti-PD1/ipilimumab (PD1+IPI) in HLA-A2*02:01 patients (pts) with metastatic uveal melanoma (mUM)
10. 823P A propensity score weighted comparison of tebentafusp or pembrolizumab versus combination ipilimumab and nivolumab in untreated metastatic uveal melanoma
11. 85P A circulating, surrogate-systemic biomarker correlates with anti-tumor benefit on LNS8801 therapy
12. 1139TiP IDE196 (darovasertib) in combination with crizotinib versus investigator’s choice of treatment as first-line therapy in HLA-A2 negative metastatic uveal melanoma
13. 1137P Efficacy of LNS8801 in melanoma patients with prior immune-related adverse events from immune-checkpoint inhibitors
14. 1127P Subgroup analysis of FOCUS phase III trial efficacy results
15. Micro RNA Expression Profiles as Adjunctive Data to Assess the Risk of Hepatocellular Carcinoma Recurrence After Liver Transplantation
16. In Light of a New Transplant Allocation Policy, Is a LDLT Program Still Justified in a High MELD Region?
17. Socioeconomic Barriers Drive Mortality in Early Stage Hepatocellular Carcinoma
18. Early Postoperative ERAS Compliance is Associated with Decreased Length of Stay and Complications Following Liver Resection
19. Establishing a Liver Transplant Protocol for Patients with Liver Confined Colorectal Liver Metastases in The United States: Insights and Outcomes From a High Volume Center
20. LBA50 Three-year survival with tebentafusp in previously untreated metastatic uveal melanoma in a phase III trial
21. 1128P A phase I dose escalation and expansion study of FHD-286, a novel BRG1/BRM (SMARCA4/SMARCA2) inhibitor, for the treatment of metastatic uveal melanoma
22. 1129P Effect of subsequent therapies including checkpoint inhibitors on overall survival in a phase III randomized trial of tebentafusp in first-line metastatic uveal melanoma: Long-term follow-up
23. 1107P BRAF mutation status does not impact outcomes with tebentafusp in advanced cutaneous melanoma
24. 1101P The effect of LNS8801 in combination with pembrolizumab in patients with treatment-refractory cutaneous melanoma
25. 1081O ctDNA reduction and clinical efficacy of the darovasertib + crizotinib (daro + crizo) combination in metastatic uveal melanoma (MUM)
26. Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers
27. Living Kidney and Liver Donor Survey to Assess Satisfaction With Donation and Elicit Ideas for Process Improvement.: Abstract# A330
28. Development of a Reliable Instrument to Assess Donor Satisfaction Among Living Organ Donors.: Abstract# A321
29. Presence of Preexisting Alloantibody Is Not Associated With Graft Failure in a Large, Single Center Experience.: Abstract# 2120
30. Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome
31. Living‐Donor Liver Transplantation in the United States: Identifying Donors at Risk for Perioperative Complications
32. Grundlagen technischer Systeme und des methodischen Vorgehens
33. Analysis of UNOS Data To Compare the Trends of Waiting List Registrations and Waiting Time for Liver Transplantation across Geographic Regions.: Abstract# 1669: Poster Board #-Session: P231-IV
34. Utilization of Simultaneous Liver-Kidney Transplants Varies Dramatically by UNOS Region.: Abstract# 1651: Poster Board #-Session: P213-IV
35. Broader Sharing Starts at Home: Digital Imaging to Augment Liver Allocation in Region 9.: Abstract# 346
36. Comparing donor outcomes by sex in living donor liver transplantation
37. Outcomes of patients with CRLM evaluated for liver transplant: Understanding the denominator
38. Transplantation of Liver Grafts From Older Donors: Impact on Recipients With Hepatitis C Virus Infection
39. Survival Outcome After Hepatic Retransplantation for Hepatitis C Virus–Positive and –Negative Recipients
40. Use of Hepatitis B Core Antibody–Positive Liver Allograft in Hepatitis C Virus–Positive and –Negative Recipients With Use of Short Course of Hepatitis B Immunoglobulin and Lamivudine
41. Change in Oral Absorption of Tacrolimus in a Liver Transplant Recipient After Reversal of Jejunoileal Bypass: Case Report
42. Does Valganciclovir Hydrochloride (Valcyte) Provide Effective Prophylaxis Against Cytomegalovirus Infection in Liver Transplant Recipients?
43. Safety, efficacy and biology of the gp100 TCR-based bispecific T cell redirector, IMCgp100 in advanced uveal melanoma in two Phase 1 trials
44. The activation state of human intrahepatic lymphocytes
45. Nephrogenic Systemic Fibrosis Among Liver Transplant Recipients: A Single Institution Experience and Topic Update
46. Arterioportal fistulae following segmental liver transplantation in a child
47. Spotlight on talimogene laherparepvec for the treatment of melanoma lesions in the skin and lymph nodes
48. 03:45 PM Abstract No. 321 Relationship between onset of liver metastases and survival after liver-directed therapy for treatment of uveal melanoma
49. 03:45 PM Abstract No. 184 Safety and efficacy of microwave ablation for uveal melanoma metastatic to the liver
50. 03:09 PM Abstract No. 317 Prolonged survival after treatment of hepatic uveal melanoma metastases using immunoembolization
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.